Business Wire

First Derivatives plc appoints David Humphries as Global Chief Operating Officer

Share

First Derivatives, a global software and consulting company, has appointed David Humphries as Chief Operating Officer reporting directly to Seamus Keating, First Derivatives’ Chief Executive Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005056/en/

David Humphries appointed as Global Chief Operating Officer (Photo: Business Wire)

David Humphries appointed as Global Chief Operating Officer (Photo: Business Wire)

Humphries will have global responsibility for First Derivatives’ operations including its business systems, methodologies, processes and controls. In this role, he will drive the company’s operational efficiency and effectiveness aligned to its strategy and in support of First Derivatives’ strong growth goals.

“We are excited to welcome David to the First Derivatives leadership team as our global COO,” said Seamus Keating, First Derivatives’ CEO. “David has a wealth of experience in technology and services companies where he has developed and operationalized growth strategies while delivering efficiency and effectiveness.”

David has worked for more than thirty years across the professional services, software and financial services markets in a series of financial, operational and M&A leadership roles. Prior to joining First Derivatives, David was the finance director of Group Transformation for the Lloyds Banking Group. Before that, David held a number of senior finance and operational roles across software and professional services at Logica plc and at Axiom Systems Limited. David started his career at Deloitte in London where he worked for ten years in their corporate finance and insolvency practices.

“It’s an exciting time to join First Derivatives,” said David Humphries. “FD has a strong services and consulting heritage in the financial markets where it supports the trading, analytics and surveillance operations for the world’s leading banks. This has enabled FD to expand Kx software into other industry sectors such as automotive, high-tech manufacturing, telco and oil and gas. There is enormous growth potential as we further operationalize our strategy focused on helping businesses change the game with actionable data insights.”

About FD
FD is a global technology provider with more than 20 years of experience working with some of the world’s largest finance, technology, automotive, utility, manufacturing and energy institutions. The Group’s Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

For further information, please visit www.firstderivatives.com or contact pr@firstderivatives.com.

Contact information

Louise Cunningham
Vice President, Marketing
louise@kx.com
+44 7580 753 918

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EasyCOV, the Virological Saliva Test for COVID19 Confirms Its Excellent Results: a Sensitivity of 88% and a Specificity of 99% in 40 Min1.10.2020 18:23:00 CESTPress release

EasyCOV, a virological saliva detection test for COVID19, has shown a sensitivity of 88% and a specificity 99% during a clinical trial performed at the testing center operated by the teaching hospital of Montpellier. The test relies on an optimized thermal protocol that provides the results in 40 minutes. EasyCOV, developed by SkillCell in collaboration with the CNRS (French National Center for Scientific Research), is a saliva test that can be run in the field and that provides results in the form of a change of color in no more than 40 minutes. Performed by a healthcare professional, the test requires the collection of 200 microliters of saliva, approximately 4 drops, from under the patient’s tongue. The sample is heated successively in two tubes using the nomadic heating device EasyVID (developed and produced by TRONICO, sister company of SkillCell). A test turning bright yellow indicates that the virus has been detected while an orange test is negative. A double-blind clinical tria

Ascend Performance Materials Announces Global Price Increase for All Vydyne® Brand Polymers, Fibers and Compounds1.10.2020 16:00:00 CESTPress release

Ascend Performance Materials announced today a global price increase for all of its Vydyne® polymers, fibers and compounds. The price increase takes effect October 15, 2020, and includes the following price changes: Materials Geography Price Increases Terms Vydyne® (PA 66) polymers, fibers and compounds North America $220/MT As contracts allow Non-contract business – price determined on an order-by-order basis Vydyne® (PA 66) polymers, fibers and compounds Asia $300/MT As contracts allow Non-contract business – price determined on an order-by-order basis Vydyne® (PA 66) polymers, fibers and compounds Europe €200/MT As contracts allow Non-contract business – price determined on an order-by-order basis Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials makes high-performance materials for everyday essentials and new technologies. Our focus is on improving quality of life and inspiring a bet

Andersen Global Adds SAGIS LP in Anguilla to Its Caribbean Platform1.10.2020 15:30:00 CESTPress release

Andersen Global bolsters its Caribbean platform through a Collaboration Agreement with full-service law firm SAGIS LP in Anguilla. In a span of three months, Andersen Global has significantly expanded its footprint throughout the region and will focus on providing additional coverage over the course of the next 18 to 24 months. Established in 2018 by four Partners, SAGIS LP provides its clients with a variety of legal services, including corporate, commercial, banking and finance, intellectual property and real estate. Additionally, the Firm’s team of lawyers are widely recognized within Chambers Global and World Trademark Review. Partner Kenneth G. Porter said, “We have been focused on delivering quality client solutions through our strategic thinking and have an in-depth understanding of our clients’ unique legal needs. Collaborating with Andersen Global positions us to meet our goal of expanding and providing more robust services, while being the firm of choice in Anguilla for local

Shionogi Announces Publication of a New Systematic Review in CHEST Highlighting the Importance of Early, Appropriate Therapy to Improve Meaningful Outcomes Like Mortality in Patients With Severe Bacterial Infections1.10.2020 15:14:00 CESTPress release

Shionogi B.V., the European subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announce the publication of a new systematic review in CHEST Journal, funded by Shionogi B.V, examining the effect of delayed appropriate antibiotic therapy on the outcomes of patients with severe bacterial infections.1 The review was carried out to characterise the impact of time to effective therapy for antimicrobials and guide treatment decisions to optimise prompt appropriate antibiotic therapy for patients most at risk. The study found that mortality was significantly lower in patients receiving appropriate therapy without delay compared with those experiencing delay.1 Severe bacterial infections requiring in-hospital treatment are associated with considerable mortality, morbidity and healthcare costs. Physicians must often initiate antibiotic therapy before the pathogen causing the infection and its drug-resistance profile

PTR Robots Introduces World’s First Mobile Lifting Robot That Both Transfers and Rehabilitates Patients1.10.2020 15:02:00 CESTPress release

PTR Robots, a Danish service-robot company, announced the world premiere of its robot that can mobilize and transfer patients. Jointly developed with healthcare professionals, the PTR Robot is the first mobile, intelligent robot solution that can flexibly move around in the healthcare and nursing sectors. While it helps individuals with impaired functions to be transferred and rehabilitated, it also relieves the strain on staff, redirecting them from labor-intensive tasks. A PTR Robot also reduces the risk of infection, because only one caregiver needs to be present to perform a patient transfer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005084/en/ PTR Robots was developed and tested in close collaboration with Zealand University Hospital, and Vonsildhave Nursing Home, operated by the nursing group Attendo. “The testing of PTR Robots really impressed us. We can see interesting perspectives in the way we can assist

Fastly Completes Acquisition of Signal Sciences1.10.2020 15:00:00 CESTPress release

Fastly, Inc. (NYSE: FSLY), provider of an edge cloud platform, today announced it has successfully completed the acquisition of Signal Sciences (“Signal Sciences”). The transaction combines Signal Sciences’ powerful web application and API security solutions with Fastly’s edge cloud platform and existing security offerings to form a unified suite of modern security tools. This robust new security portfolio, designed for the way developers work, unlocks innovation at the edge and removes silos between developers, operations, and security teams to shorten development cycles and protect websites and web applications alike. “We are excited to close this transaction and welcome the talented team at Signal Sciences to Fastly,” said Joshua Bixby, Chief Executive Officer of Fastly. “Our companies are similarly focused on giving developers more control and visibility by designing offerings that embrace modern DevOps practices. Together with Signal Sciences, we will deliver a web application and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom